Skip to content

Early Diagnostic Telehealth Pilot for Moderate- and High-Risk Children: Evaluating Assessment Protocols and Efficiency in Georgia's Early Intervention Program

Early Diagnostic Telehealth Pilot for Moderate- and High-risk Children: Evaluating Protocols for Children in Georgia's Early Intervention Program

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07623759
Enrollment
100
Registered
2026-06-03
Start date
2026-06-01
Completion date
2027-06-01
Last updated
2026-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism, Autism Spectrum Disorder

Keywords

Autism, Early Intervention

Brief summary

This pilot study includes children identified as moderate- as well as high-risk for autism spectrum disorder (ASD) within Georgia's Babies Can't Wait (BCW) Early Intervention (EI) program. The project will evaluate the feasibility, acceptability, and implementation of a diagnostic protocol, including optional measures, through measures of recruitment, retention, adherence, provider confidence, and time from referral to report completion. It will also examine which child diagnostic measures are essential and needed to improve psychologists' diagnostic confidence. Caregiver, early intervention provider, and clinician experiences and satisfaction before, during, and after assessment will be assessed to evaluate protocol acceptability, knowledge, and access to services. Outcomes will be analyzed using the RE-AIM Framework (reach, effectiveness, adoption, implementation, maintenance) and compared across BCW districts and child characteristics, including changes in autism screening, referral, and evaluation rates over time.

Detailed description

The objective of this study is to develop, pilot, and evaluate a telehealth diagnostic protocol for assessing toddlers identified as moderate- or high-risk for autism spectrum disorder (ASD) within Georgia's Babies Can't Wait (BCW) Early Intervention (EI) program. Many BCW children with moderate- or high-risk screening results face long wait times and limited access to diagnostic evaluations. This pilot will evaluate how many of these assessments can be completed entirely via a streamlined telehealth protocol and the level of diagnostic confidence achieved. It is hypothesized that the EDRM-E will increase access to timely, evidence-based autism evaluations and yield diagnostic outcomes comparable to in-person assessments based on DSM-5-TR criteria. Secondary aims include identifying which additional assessment measures increase clinician confidence and are most acceptable to families and providers. It is hypothesized that moderate-risk children will require more in-depth evaluation and that families receiving expanded assessments will report higher satisfaction and acceptability. A further objective is to examine family, BCW provider, and clinician satisfaction, understanding, and access to services following participation in the EDRM-E pilot. No data will be submitted to the FDA, and no algorithm, product, or software will be commercialized or used outside Emory.

Interventions

BEHAVIORALEarly Diagnostic Response Model Expanded

A telehealth diagnostic protocol for assessing toddlers identified as moderate- or high-risk for autism spectrum disorder (ASD) within Georgia's Babies Can't Wait (BCW) Early Intervention (EI) program. This pilot will evaluate how many of the initial assessments can be completed entirely via a streamlined telehealth protocol and the level of diagnostic confidence achieved.

Sponsors

Emory University
Lead SponsorOTHER
Georgia Department of Public Health
CollaboratorUNKNOWN

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Months to 36 Months
Healthy volunteers
No

Inclusion criteria

* Child is enrolled in a participating BCW district. * Child is 16-36 months of age at the time of referral. * Child is identified as moderate- or high-risk on the M-CHAT-R/F * BCW provider submits a referral to the EDRM-E pilot by 33 months of age. * Parent/guardian has basic English proficiency in order to complete intake forms and in-depth interview, and the child has exposure to English at home or in out-of-home care. * Documentation of the M-CHAT-R/F screening results and parental consent to refer is completed and submitted.

Exclusion criteria

* Families making self-referrals to the EAC or referred from non-onboarded BCW districts. * Child is older than 33 months at referral. * Non-English speaking families due to staffing and resource limitations as the consent, parent interview and child assessment would need to be done and accessible in other languages and are not available within this study scope at this time. .

Design outcomes

Primary

MeasureTime frameDescription
Number of moderate and high-risk referral assessments that were completed entirely via a streamlined telehealth protocolMonthly until the end of the study (approximately one year)Number of moderate and high-risk referral assessments that can be completed entirely via streamlined telehealth protocol
Number of participants referred to the Early Diagnostic Response Model Expanded (EDRM-E)End of study (up to 16 weeks post-intervention)Monthly numbers of high-risk referrals to the EDRM-E pilot project and total number of referrals made to the EDRM-E at the end of the study.
Number of participants consented in the Early Diagnostic Response Model Expanded (EDRM-E) studyMonthly until the end of the study (approximately one year)Monthly number of families referred who consent to EDRM-E participation
Response rate in the Early Diagnostic Response Model Expanded (EDRM-E) studyMonthly until the end of the study (approximately one year)Response rate will be calculated at project end using the formula \[# of families who consented / # of families referred to project\] x 100 = response rate)
Number of participants that completed the Early Diagnostic Response Model Expanded (EDRM-E) studyEvery 3 months (Quarterly) until end of study (approximately one year)Quarterly numbers of participants that completed the EDRM-E assessment protocol and total number of participants who completed EDRM-E assessment protocol at study conclusion
Time from referral to completion of the programUp to 12 weeks post-interventionIndividual calculation of time from BCW referral to final summary report sent to family using the formula: Date of Final Report sent to family - Date of referral from BCW =Time in EDRM-E pilot

Secondary

MeasureTime frameDescription
Number of moderate and high-risk referrals by BCW districtEvery 3 months (Quarterly) until end of study (approximately one year), Up to 12 weeks post-interventionNumber of moderate-high risk referral assessments by specific BCW district. Monthly, Quarterly, and Total numbers of participants who completed EDRM-E pilot assessment.
Number of moderate and high-risk referral by child factorsEvery 3 months (Quarterly) until end of study (approximately one year), Up to 12 weeks post-interventionNumber of high-risk referral assessments by child factors. Monthly, Quarterly, and Total numbers of participants who completed EDRM-E pilot assessment.
Number of moderate and high-risk referrals by clinician settingEvery 3 months (Quarterly) until end of study (approximately one year), Up to 12 weeks post-interventionNumber of high-risk referral assessments by clinician setting. Monthly, Quarterly, and Total numbers of participants who completed EDRM-E pilot assessment.
Number of participants with additional information collected to make a final DSM-5 conclusionEvery 3 months (Quarterly) until end of study (approximately one year), Up to 12 weeks post-interventionNumber of participants with additional information collected to make a final DSM-5 conclusion
Parent satisfaction of EDRM-E assessment surveyAt completion of EDRM-E assessment (4 weeks post-intervention)Administered at the end of individual EDRM-E assessment. Satisfaction surveys will use a Likert-scale of 1-5 with 1 being strongly disagree and 5 being strongly agree as well as 0 being not applicable/unknown. Higher scores indicate more satisfaction with specific aspect of EDRM project. Total score: 0 to 110.
BCW provider(s) Service Coordinator satisfaction with EDRM-E assessment surveyAt completion of EDRM-E assessment (4 weeks post-intervention)Administered at end of individual EDRM-E assessment. Satisfaction surveys will use a Likert-scale of 1-5 with 1 being strongly disagree and 5 being strongly agree as well as 0 being not applicable/unknown. Higher scores indicate more satisfaction with specific aspect of EDRM-E project.
Parent satisfaction with access to treatment survey3 months after completion of EDRM-E assessmentParent satisfaction with access to treatment survey Administered 3-months after completion of EDRM-E assessment. Satisfaction surveys will use a Likert-scale of 1-5 with 1 being strongly disagree and 5 being strongly agree as well as 0 being not applicable/unknown. Higher scores indicate more satisfaction with specific aspect of EDRM-E project. Total score: 0 to 15.
BCW provider(s) Early Intervention Coordinator satisfaction with EDRM-E pilot surveyEvery 3 months (Quarterly) until end of study (approximately one year), Up to 12 weeks postinterventionCompleted every 3 months (Quarterly). Satisfaction surveys will use a Likert-scale of 1-5 with 1 being strongly disagree and 5 being strongly agree as well as 0 being not applicable/unknown. Higher scores indicate more satisfaction with specific aspect of EDRM project. Total score: 0 to 55
Number of families screened moderate and high-risk for ASD and referred for an evaluationThrough study completion, an average of 1 yearNumber of families screened moderate and high-risk for ASD and referred for an evaluation
Number of families who received ASD evaluation by the end of the study through the pilot versus other meansThrough study completion, an average of 1 yearNumber of families who received ASD evaluation by the end of the study through the pilot versus other means

Countries

United States

Contacts

CONTACTAllison J Schwartz, PhD
allison.schwartz@emory.edu404-727-6865
PRINCIPAL_INVESTIGATORAllison J Schwartz, PhD

Emory University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 4, 2026